This prospective, randomized, double-blind, placebo-controlled trial included 71 patients with severe intractable atopic dermatitis who were given an 8-week treatment with oral Xiao-Feng-San (XFS; 47 patients).
The decrease in the lesion score in the treatment group at 8 weeks was significantly greater than that of the placebo group (79.7 vs. 13.5, p less than 0.001).
Patients reported no side effects from treatment, although some commented on the unpalatability of the medication.
This study from Taiwan suggest that the traditional Chinese herbal medicine XFS may be an alternative choice of therapy for severe, refractory atopic dermatitis.
References:
The Efficacy and Safety of a Chinese Herbal Product (Xiao-Feng-San) for the Treatment of Refractory Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Cheng HM, Chiang LC, Jan YM, Chen GW, Li TC. Int Arch Allergy Immunol. 2010 Dec 22;155(2):141-148.
No Chinese manufacturer has successfully registered herbal medicinal products in the EU - all will be banned in May 2011. The Lancet, 2011.
The quest to find the "magic" Chinese herbal formula continues: Danggui Buxue Tang helps asthmatic MICE http://goo.gl/Bdfle
The quest to find the "magic" Chinese herbal formula continues: Danggui Buxue Tang helps asthmatic MICE http://goo.gl/Bdfle
Image source: Chinese herbology, Wikipedia, public domain.
No comments:
Post a Comment